Telehealth companies selling compounded drugs are making modest inroads into the market for popular weight loss drugs that Big Pharma spent decades and billions of dollars to develop and bring to market. The compounded...more
6/13/2025
/ Corporate Practice of Medicine ,
Drug Compounding ,
Eli Lilly ,
False Advertising ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Litigation Strategies ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Telehealth ,
Unfair or Deceptive Trade Practices
California Senate Bill 478 (SB 478) will prohibit hidden fees for goods and services beginning July 1, 2024. The amendment to the California Legal Remedies Act (California Civil Code Section 1770(a)(29)) aims to eliminate...more